(Q36552744)

14 August 2017

title

Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials (English)

1 reference

multicenter clinical trial

14 August 2017

main subject

1 reference

Jennifer F Hoy

7

0 references

Wafaa El-Sadr

5

object named as

Wafaa M El-Sadr

1 reference

14 August 2017

Alan R Lifson

1

1 reference

14 August 2017

Frank S Rhame

2

1 reference

14 August 2017

Waldo H Belloso

3

1 reference

14 August 2017

Ulrik B Dragsted

4

1 reference

14 August 2017

Jose M Gatell

6

1 reference

14 August 2017

Eric A Krum

8

1 reference

14 August 2017

Ray Nelson

9

1 reference

14 August 2017

Court Pedersen

10

1 reference

14 August 2017

Sarah L Pett

11

1 reference

14 August 2017

Richard T Davey

12

1 reference

14 August 2017

language of work or name

1 reference

1 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

7

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

125-141

1 reference

Immune-based therapies: a review of clinical endpoints used in trials of selected immunologic agents

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

Natural history of opportunistic disease in an HIV-infected urban clinical cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

Disseminated Penicillium marneffei infection in southeast Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

Differences in difficulty adjudicating clinical events in patients with advanced HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

The AIDS dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

Composite outcomes in randomized trials: greater precision but with greater uncertainty?

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

Some issues with composite endpoints in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

Grade 4 Events Are as Important as AIDS Events in the Era of HAART

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

Better reporting of harms in randomized trials: an extension of the CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

The Need for Adverse Effects Reporting Standards in Oncology Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2F7MER-XFA7-1762-E2WR

10.1310/7MER-XFA7-1762-E2WR

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference